reference/18952195

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18952195

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	0344-0338
issueIdentifier	5
pageRange	152914-
publicationName	Pathology - Research and Practice
startingPage	152914
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fb85f23a6ae90eb4bbd5182c64fd893a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_57f04acb1defe3029a5543210daf8ee5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_76a50f1b6d5cbee778d4c02d0a749b05 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0e26e00eee5359927c99b3d9ab91e8d5
bibliographicCitation	Yuan XD, Wang JW, Fang Y, Qian Y, Gao S, Fan YC, Wang K. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression. Pathol Res Pract. 2020 May;216(5):152914. doi: 10.1016/j.prp.2020.152914. PMID: 32147273.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9126-679X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae772591149be67bdedeedcaf3b0551a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a724474f2d724f95f9aa39a10b3f0c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97c3b3b24539bfc0c95fc09caabeff8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_952ff21edec53e16d2b0b384b9b82f7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67702bdf954b3dcadf4ac04b275eafa4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4646498f757290d67df69d3d2e2589f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e77d867a46b6fb0b9d68b9b57b7887ba
date	202005
identifier	https://pubmed.ncbi.nlm.nih.gov/32147273 https://doi.org/10.1016/j.prp.2020.152914
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6536 https://portal.issn.org/resource/ISSN/0344-0338
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression
discusses	http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0024234 http://id.nlm.nih.gov/mesh/M0262287
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D006528Q000473 http://id.nlm.nih.gov/mesh/D015820Q000235 http://id.nlm.nih.gov/mesh/D008113Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D008113Q000821 http://id.nlm.nih.gov/mesh/D007963 http://id.nlm.nih.gov/mesh/D014408Q000097 http://id.nlm.nih.gov/mesh/D011401 http://id.nlm.nih.gov/mesh/D019694Q000150 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006528Q000175 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019175 http://id.nlm.nih.gov/mesh/D006528Q000821 http://id.nlm.nih.gov/mesh/D008113Q000175
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07edfd5399a4297179b0eb6e7ec0142a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b6f3ed43d6c872c60676fec4bb28ff75 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_95d926625e5919a35cb6aa367ba7b069 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fadc3c8509db129e10ef4cfccf6efc5d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8345 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_20d7cafd7ff5b8e5fec75126ca949f28

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1012

Total number of triples: 61.